Kinetics	O
of	O
cytokine	O
and	O
NFAT	O
gene	O
expression	O
in	O
human	B-cell_line
interleukin-2-dependent	I-cell_line
T	I-cell_line
lymphoblasts	I-cell_line
stimulated	O
via	O
T-cell	B-protein
receptor	I-protein
.	O

T	B-cell_type
cells	I-cell_type
respond	O
to	O
mitogenic	O
or	O
antigenic	O
stimulation	O
by	O
proliferation	O
and	O
by	O
turning	O
on	O
cytokine	O
gene	O
expression	O
.	O

Here	O
we	O
have	O
analysed	O
the	O
kinetics	O
and	O
nature	O
of	O
cytokine	O
production	O
in	O
human	B-cell_type
peripheral	I-cell_type
blood-derived	I-cell_type
T	I-cell_type
lymphoblasts	I-cell_type
stimulated	O
with	O
anti-CD3	B-protein
antibodies	I-protein
or	O
Lens	B-protein
culinaris	I-protein
lectin	I-protein
(	O
LCL	B-protein
)	O
.	O

T	B-cell_type
cells	I-cell_type
were	O
purified	O
from	O
peripheral	B-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
(	O
PBMC	B-cell_type
)	O
and	O
primarily	O
activated	O
with	O
anti-CD3	B-protein
antibodies	I-protein
and	O
cultured	O
in	O
the	O
presence	O
of	O
interleukin-2	B-protein
(	O
IL-2	B-protein
)	O
.	O

Anti-CD3-restimulated	O
T	B-cell_type
cells	I-cell_type
(	O
mainly	O
CD8+	O
)	O
produced	O
IL-2	B-protein
,	O
interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
and	O
tumour	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
and	O
low	O
levels	O
of	O
IL-4	B-RNA
and	I-RNA
IL-10	I-RNA
transcripts	I-RNA
and	O
proteins	O
.	O

No	O
IL-6	B-DNA
gene	I-DNA
expression	O
was	O
observed	O
.	O

In	O
LCL-stimulated	B-cell_type
cells	I-cell_type
the	O
cytokine	O
production	O
pattern	O
was	O
very	O
similar	O
.	O

Steady-state	O
mRNA	O
levels	O
of	O
IL-2	B-protein
,	O
IL-10	B-protein
and	O
IFN-gamma	B-protein
peaked	O
at	O
3	O
hr	O
after	O
anti-CD3	O
stimulation	O
and	O
declined	O
rapidly	O
thereafter	O
.	O

The	O
kinetics	O
of	O
TNF-alpha	B-RNA
mRNA	I-RNA
expression	O
was	O
faster	O
,	O
being	O
at	O
its	O
peak	O
level	O
1	O
hr	O
after	O
stimulation	O
.	O

Anti-CD3-stimulated	O
IL-2	B-DNA
gene	I-DNA
expression	O
was	O
down-regulated	O
by	O
protein	O
synthesis	O
inhibitor	O
,	O
whereas	O
IL-10	B-DNA
,	I-DNA
IFN-gamma	I-DNA
and	I-DNA
TNF-alpha	I-DNA
genes	I-DNA
were	O
readily	O
induced	O
independent	O
of	O
ongoing	O
protein	O
synthesis	O
.	O

T-cell	B-protein
receptor	I-protein
stimulation	O
also	O
induced	O
a	O
very	O
rapid	O
expression	O
of	O
c-jun	B-DNA
,	I-DNA
c-fos	I-DNA
and	I-DNA
NFATc1	I-DNA
(	I-DNA
NFATc	I-DNA
)	I-DNA
genes	I-DNA
,	O
the	O
gene	O
products	O
of	O
which	O
are	O
involved	O
in	O
cytokine	O
gene	O
expression	O
.	O

In	O
conclusion	O
,	O
the	O
cytokines	B-protein
synthesized	O
by	O
IL-2-dependent	B-cell_type
T	I-cell_type
cells	I-cell_type
were	O
predominantly	O
IL-2	B-protein
,	O
IFN-gamma	B-protein
and	O
TNF-alpha	B-protein
.	O

Immunology	NULL
1998	NULL
93	NULL
350-357	NULL
Kinetics	NULL
of	NULL
cytokine	NULL
and	NULL
NFAT	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
interleukin-2-dependent	NULL
T	NULL
lymphoblasts	NULL
stimulated	NULL
via	NULL
T-cell	NULL
receptor	NULL
T.	NULL
SARENEVA	NULL
,	NULL
*	NULL
S.	NULL
MATIKAINEN	NULL
,	NULL
*	NULL
J.	NULL
VANHATALO	NULL
,	NULL
*	NULL
K.	NULL
MELEN	NULL
,	NULL
*	NULL
J.	NULL
PELKONENt	NULL
&	NULL
I.	NULL
JULKUNEN*	NULL
*Department	NULL
of	NULL
Virology	NULL
,	NULL
Laboratory	NULL
of	NULL
Viral	NULL
and	NULL
Molecular	NULL
Immunology	NULL
,	NULL
National	NULL
Public	NULL
Health	NULL
Institute	NULL
,	NULL
Helsinki	NULL
,	NULL
and	NULL
{	NULL
Department	NULL
of	NULL
Clinical	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
Kuopio	NULL
,	NULL
Kuopio	NULL
,	NULL
Finland	NULL
SUMMARY	NULL
T	NULL
cells	NULL
respond	NULL
to	NULL
mitogenic	NULL
or	NULL
antigenic	NULL
stimulation	NULL
by	NULL
proliferation	NULL
and	NULL
by	NULL
turning	NULL
on	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
analysed	NULL
the	NULL
kinetics	NULL
and	NULL
nature	NULL
of	NULL
cytokine	NULL
production	NULL
in	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
antibodies	NULL
or	NULL
Lens	NULL
culinaris	NULL
lectin	NULL
(	NULL
LCL	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
and	NULL
primarily	NULL
activated	NULL
with	NULL
anti-CD3	NULL
antibodies	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
.	NULL

Anti-CD3-restimulated	NULL
T	NULL
cells	NULL
(	NULL
mainly	NULL
CD8	NULL
*	NULL
)	NULL
produced	NULL
IL-2	NULL
,	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-4	NULL
)	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
IL-4	NULL
and	NULL
IL-10	NULL
transcripts	NULL
and	NULL
proteins	NULL
.	NULL

No	NULL
IL-6	NULL
gene	NULL
expression	NULL
was	NULL
observed	NULL
.	NULL

In	NULL
LCL-stimulated	NULL
cells	NULL
the	NULL
cytokine	NULL
production	NULL
pattern	NULL
was	NULL
very	NULL
similar	NULL
.	NULL

Steady-state	NULL
mRNA	NULL
levels	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
and	NULL
IFN-y	NULL
peaked	NULL
at	NULL
3	NULL
hr	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
and	NULL
declined	NULL
rapidly	NULL
thereafter	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
TNF-x	NULL
mRNA	NULL
expression	NULL
was	NULL
faster	NULL
,	NULL
being	NULL
at	NULL
its	NULL
peak	NULL
level	NULL
1	NULL
hr	NULL
after	NULL
stimulation	NULL
.	NULL

Anti-CD3-stimulated	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
down-regulated	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
,	NULL
whereas	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
genes	NULL
were	NULL
readily	NULL
induced	NULL
independent	NULL
of	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
.	NULL

T-cell	NULL
receptor	NULL
stimulation	NULL
also	NULL
induced	NULL
a	NULL
very	NULL
rapid	NULL
expression	NULL
of	NULL
c-jun	NULL
,	NULL
c-fos	NULL
and	NULL
NFATcl	NULL
(	NULL
NFATc	NULL
)	NULL
genes	NULL
,	NULL
the	NULL
gene	NULL
products	NULL
of	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
cytokines	NULL
synthesized	NULL
by	NULL
IL-	NULL
2-dependent	NULL
T	NULL
cells	NULL
were	NULL
predominantly	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

INTRODUCTION	NULL
T	NULL
cells	NULL
are	NULL
important	NULL
regulators	NULL
of	NULL
immune	NULL
responses	NULL
in	NULL
vivo	NULL
.	NULL

T-cell	NULL
activation	NULL
is	NULL
specified	NULL
by	NULL
T-cell	NULL
receptor	NULL
complex	NULL
(	NULL
TCR-CD3	NULL
)	NULL
,	NULL
which	NULL
upon	NULL
interaction	NULL
with	NULL
antigen-presenting	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
molecules	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T-cell	NULL
effector	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
cytokine	NULL
production	NULL
and	NULL
cytolytic	NULL
activity	NULL
.	NULL
``	NULL

T	NULL
cells	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
functionally	NULL
distinct	NULL
subpopulations	NULL
,	NULL
namely	NULL
cytotoxic	NULL
CD8	NULL
*	NULL
and	NULL
CD4*	NULL
T	NULL
helper	NULL
cells	NULL
T	NULL
helper	NULL
cells	NULL
can	NULL
further	NULL
be	NULL
subdivided	NULL
into	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
Th2	NULL
cells	NULL
based	NULL
on	NULL
their	NULL
characteristic	NULL
cytokine	NULL
expression	NULL
profiles	NULL
.	NULL

``	NULL
~°	NULL
Cytokines	NULL
,	NULL
which	NULL
are	NULL
essential	NULL
in	NULL
directing	NULL
the	NULL
immune	NULL
response	NULL
towards	NULL
cell-mediated	NULL
-	NULL
immunity	NULL
,	NULL
-	NULL
include	NULL
Thl-type	NULL
-	NULL
cytokines	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

Th2-type	NULL
cytokines	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
and	NULL
IL-10	NULL
enhance	NULL
and	NULL
support	NULL
humoral	NULL
Received	NULL
23	NULL
September	NULL
1997	NULL
;	NULL
revised	NULL
30	NULL
November	NULL
1997	NULL
;	NULL
accepted	NULL
30	NULL
November	NULL
1997	NULL
.	NULL

Abbreviations	NULL
:	NULL
AP-1	NULL
,	NULL
activated	NULL
protein	NULL
1	NULL
;	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogen-ase	NULL
;	NULL
LCL	NULL
,	NULL
Lens	NULL
culinaris	NULL
lectin	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Correspondence	NULL
:	NULL
Dr	NULL
T.	NULL
Sareneva	NULL
,	NULL
National	NULL
Public	NULL
Health	NULL
Institute	NULL
,	NULL
Mannerheimintie	NULL
166	NULL
,	NULL
FIN-00300	NULL
Helsinki	NULL
,	NULL
Finland	NULL
.	NULL

immune	NULL
responses	NULL
as	NULL
well	NULL
as	NULL
they	NULL
counteract	NULL
the	NULL
activating	NULL
effects	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
on	NULL
cell-mediated	NULL
immunity	NULL
.	NULL
``	NULL

Activated	NULL
CD8	NULL
*	NULL
cells	NULL
produce	NULL
IFN-y	NULL
preferentially	NULL
but	NULL
some	NULL
subsets	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
able	NULL
to	NULL
produce	NULL
Th2-type	NULL
cytokines	NULL
as	NULL
well	NULL
.	NULL

``	NULL
*	NULL
Since	NULL
CD8*	NULL
T	NULL
cells	NULL
are	NULL
already	NULL
active	NULL
early	NULL
in	NULL
infection	NULL
,	NULL
their	NULL
role	NULL
in	NULL
directing	NULL
specific	NULL
immune	NULL
responses	NULL
is	NULL
potentially	NULL
very	NULL
important	NULL
.	NULL
``	NULL

At	NULL
present	NULL
,	NULL
there	NULL
is	NULL
no	NULL
detailed	NULL
view	NULL
of	NULL
the	NULL
quality	NULL
,	NULL
quantity	NULL
and	NULL
kinetics	NULL
of	NULL
cytokine	NULL
production	NULL
in	NULL
activated	NULL
human	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
T-cell	NULL
signalling	NULL
has	NULL
been	NULL
under	NULL
active	NULL
investigation	NULL
for	NULL
several	NULL
years	NULL
.	NULL

T-cell	NULL
receptor	NULL
stimulation	NULL
activates	NULL
several	NULL
signal	NULL
transduction	NULL
pathways	NULL
including	NULL
ras	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
calcineurin	NULL
,	NULL
followed	NULL
by	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-xB	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
and	NULL
activated	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
transcription	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
These	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
initiating	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-4	NULL
)	NULL
and	NULL
IFN-y	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
cytokine	NULL
expression	NULL
profiles	NULL
in	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
,	NULL
predominantly	NULL
CD8	NULL
*	NULL
,	NULL
T	NULL
lymphoblasts	NULL
.	NULL

Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
anti-CD3	NULL
antibody-stimulated	NULL
or	NULL
LCL-stimulated	NULL
cells	NULL
was	NULL
analysed	NULL
by	NULL
quantitative	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
,	NULL
and	NULL
Northern	NULL
blotting	NULL
as	NULL
well	NULL
as	NULL
at	NULL
the	NULL
level	NULL
of	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
351	NULL
protein	NULL
production	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
T	NULL
lymphoblasts	NULL
produced	NULL
preferentially	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
and	NULL
minimal	NULL
amounts	NULL
of	NULL
IL-4	NULL
and	NULL
IL-10	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
strong	NULL
upregulation	NULL
of	NULL
c-jun	NULL
,	NULL
c-fos	NULL
and	NULL
NFATcl	NULL
mRNA	NULL
expression	NULL
was	NULL
seen	NULL
,	NULL
which	NULL
is	NULL
likely	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
efficient	NULL
induction	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
Anti-CD3	NULL
[	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
CRL	NULL
8001	NULL
]	NULL
antibody-containing	NULL
ascites	NULL
fluid	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Kaartinen	NULL
(	NULL
Haartman	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Helsinki	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Phorbol	NULL
12-myristate-13-acetate	NULL
(	NULL
PMA	NULL
;	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
Lens	NULL
culinaris	NULL
lectin	NULL
(	NULL
LCL	NULL
;	NULL
10	NULL
ug/ml	NULL
)	NULL
from	NULL
the	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
(	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Cell	NULL
isolation	NULL
and	NULL
culture	NULL
Leucocyte-rich	NULL
buffy	NULL
coats	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
blood	NULL
donors	NULL
(	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Biotechnology	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
centrifugation	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
most	NULL
of	NULL
the	NULL
adherent	NULL
cells	NULL
(	NULL
monocytes	NULL
)	NULL
were	NULL
removed	NULL
by	NULL
binding	NULL
to	NULL
plastic	NULL
plates	NULL
(	NULL
Falcon	NULL
Multiwell	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Franklin	NULL
Lakes	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

Non-adherent	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
further	NULL
purified	NULL
by	NULL
passing	NULL
them	NULL
through	NULL
nylon	NULL
wool	NULL
columns	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
(	NULL
Integro	NULL
,	NULL
Zaandam	NULL
,	NULL
the	NULL
Netherlands	NULL
)	NULL
,	NULL
20mm	NULL
HEPES	NULL
buffer	NULL
,	NULL
2mM	NULL
-	NULL
L-glutamine	NULL
,	NULL
penicillin	NULL
(	NULL
0-6	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
60	NULL
ug/ml	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
activated	NULL
on	NULL
tissue	NULL
culture	NULL
plates	NULL
precoated	NULL
with	NULL
an	NULL
optimal	NULL
dilution	NULL
of	NULL
anti-CD3	NULL
antibody-containing	NULL
ascites	NULL
fluid	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
100	NULL
U/ml	NULL
;	NULL
Aldesleukin	NULL
,	NULL
Chiron	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
1	NULL
week	NULL
.	NULL

After	NULL
this	NULL
,	NULL
IL-2-containing	NULL
fresh	NULL
media	NULL
was	NULL
added	NULL
at	NULL
3-5-day	NULL
intervals	NULL
.	NULL

To	NULL
gain	NULL
more	NULL
information	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
different	NULL
T-cell	NULL
types	NULL
we	NULL
collected	NULL
cell	NULL
samples	NULL
at	NULL
10-day	NULL
intervals	NULL
and	NULL
analysed	NULL
them	NULL
on	NULL
a	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACScan	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
both	NULL
fluorescein-	NULL
and	NULL
phycoer-ythrin-conjugated	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
various	NULL
blood	NULL
cell	NULL
markers	NULL
.	NULL

Antibody	NULL
panels	NULL
specific	NULL
for	NULL
CD14/45	NULL
,	NULL
CD3/4	NULL
,	NULL
CD3/8	NULL
,	NULL
CD3/19	NULL
,	NULL
CD3/16	NULL
+56	NULL
,	NULL
CD4/8	NULL
molecules	NULL
and	NULL
isotype	NULL
control	NULL
IgG1l/IgG2a	NULL
antibodies	NULL
labelled	NULL
with	NULL
fluor-escein	NULL
and	NULL
phycoerythrin	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
used	NULL
.	NULL

Cell	NULL
samples	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
SimulSet	NULL
,	NULL
version	NULL
1.1	NULL
and	NULL
CellQuest	NULL
,	NULL
version	NULL
1.2.	NULL
software	NULL
programs	NULL
.	NULL

Initially	NULL
,	NULL
CD4*	NULL
cells	NULL
formed	NULL
the	NULL
majority	NULL
,	NULL
but	NULL
during	NULL
the	NULL
follow-up	NULL
studies	NULL
the	NULL
cellular	NULL
population	NULL
changed	NULL
towards	NULL
the	NULL
CD8	NULL
*	NULL
subtype	NULL
.	NULL

At	NULL
10	NULL
days	NULL
after	NULL
anti-CD3/IL-2	NULL
stimulation	NULL
the	NULL
cell	NULL
population	NULL
was	NULL
approximately	NULL
70	NULL
%	NULL
CD8	NULL
and	NULL
30	NULL
%	NULL
CD4	NULL
.	NULL

At	NULL
later	NULL
times	NULL
there	NULL
was	NULL
a	NULL
clear	NULL
overgrowth	NULL
of	NULL
CD8	NULL
*	NULL
cells	NULL
and	NULL
over	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
of	NULL
the	NULL
CD8	NULL
*	NULL
subtype	NULL
after	NULL
30	NULL
days	NULL
of	NULL
cultivation	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
the	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Quantification	NULL
of	NULL
cytokine	NULL
mRNA	NULL
by	NULL
RT-PCR	NULL
Relative	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
quantitative	NULL
RT-PCR	NULL
assay	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
1:75	NULL
nmol	NULL
of	NULL
random	NULL
primer	NULL
were	NULL
mixed	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
18	NULL
pl	NULL
,	NULL
heated	NULL
to	NULL
65°	NULL
for	NULL
5	NULL
min	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
5	NULL
ul	NULL
of	NULL
5	NULL
x	NULL
RT	NULL
buffer	NULL
(	NULL
350mm	NULL
KCI	NULL
,	NULL
50	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
250	NULL
mm	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8-3	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
dNTP	NULL
(	NULL
10	NULL
mm	NULL
each	NULL
)	NULL
and	NULL
1	NULL
ul	NULL
(	NULL
5U	NULL
)	NULL
of	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
42°	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

The	NULL
enzyme	NULL
was	NULL
inactivated	NULL
by	NULL
adding	NULL
25	NULL
ul	NULL
of	NULL
TE	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
lmm	NULL
EDTA	NULL
,	NULL
pH	NULL
8:0	NULL
)	NULL
and	NULL
heating	NULL
the	NULL
sample	NULL
to	NULL
70°	NULL
for	NULL
5	NULL
min	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
50	NULL
pul	NULL
with	NULL
0-2	NULL
mm	NULL
dNTP	NULL
,	NULL
0-3	NULL
um	NULL
of	NULL
primers	NULL
,	NULL
1	NULL
U	NULL
of	NULL
Taq	NULL
polymerase	NULL
(	NULL
Dynazyme	NULL
II	NULL
,	NULL
Finnzymes	NULL
,	NULL
Espoo	NULL
,	NULL
Finland	NULL
)	NULL
and	NULL
a	NULL
standard	NULL
buffer	NULL
supplemented	NULL
with	NULL
1-5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cytokine-specific	NULL
cDNA	NULL
was	NULL
quantified	NULL
in	NULL
two	NULL
steps	NULL
to	NULL
increase	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
assay	NULL
.	NULL

First	NULL
,	NULL
cDNA	NULL
samples	NULL
(	NULL
1	NULL
ul/reaction	NULL
)	NULL
were	NULL
amplified	NULL
for	NULL
15	NULL
cycles	NULL
with	NULL
cytokine-specific	NULL
primer	NULL
pairs	NULL
.	NULL

Second	NULL
,	NULL
3	NULL
ul	NULL
of	NULL
this	NULL
amplification	NULL
product	NULL
was	NULL
divided	NULL
into	NULL
five	NULL
tubes	NULL
containing	NULL
a	NULL
decreasing	NULL
amount	NULL
of	NULL
multi-specific	NULL
plasmid	NULL
DNA	NULL
and	NULL
the	NULL
second	NULL
round	NULL
of	NULL
the	NULL
PCR	NULL
amplification	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
same	NULL
cytokine-specific	NULL
primer	NULL
pairs	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
L.	NULL
sooog—	NULL
C	NULL
is	NULL
G	NULL
ifn-y	NULL
|	NULL
4000	NULL
~	NULL
I	NULL
nro	NULL
3000	NULL
|-	NULL
__	NULL
2000	NULL
E	NULL
s	NULL
|	NULL
|	NULL
E	NULL
1000	NULL
|-	NULL
|	NULL
2	NULL
[	NULL
|	NULL
‘	NULL
e	NULL
§	NULL
,	NULL
L	NULL
e	NULL
O	NULL
wre	NULL
N	NULL
W	NULL
3	NULL
6	NULL
©	NULL
£0	NULL
|	NULL
s	NULL
|	NULL
€	NULL
|	NULL
-	NULL
GU	NULL
ice	NULL
=	NULL
150	NULL
|	NULL
<	NULL
G	NULL
is	NULL
&	NULL
T	NULL
W	NULL
1-40	NULL
|	NULL
|	NULL
|	NULL
100	NULL
|-	NULL
H7	NULL
P	NULL
|	NULL
]	NULL
50	NULL
|-	NULL
|	NULL
|	NULL
0	NULL
(	NULL
1	NULL
Ci	NULL
mmm	NULL
L_	NULL
|	NULL
cas	NULL
o	NULL
3	NULL
3	NULL
Time	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
hr	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Quantitative	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
in	NULL
anti-CD3-stimulated	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
cells	NULL
obtained	NULL
from	NULL
healthy	NULL
blood	NULL
donors	NULL
were	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
antibodies	NULL
and	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
for	NULL
4	NULL
weeks	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
0	NULL
hr	NULL
)	NULL
or	NULL
were	NULL
restimulated	NULL
with	NULL
anti-CD3	NULL
antibodies	NULL
followed	NULL
by	NULL
collection	NULL
of	NULL
the	NULL
cells	NULL
at	NULL
1	NULL
hr	NULL
and	NULL
3	NULL
hr	NULL
after	NULL
the	NULL
stimulation	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
the	NULL
relative	NULL
quantities	NULL
of	NULL
different	NULL
cytokine	NULL
transcripts	NULL
were	NULL
determined	NULL
by	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
data	NULL
represents	NULL
the	NULL
mean	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Cytokine	NULL
mRNA	NULL
levels	NULL
were	NULL
standardized	NULL
according	NULL
to	NULL
corresponding	NULL
B	NULL
,	NULL
-microglobulin	NULL
mRNA	NULL
levels	NULL
.	NULL

352	NULL
T.	NULL
Sareneva	NULL
et	NULL
al	NULL
.	NULL

Time	NULL
after	NULL
stimulation	NULL
(	NULL
hr	NULL
)	NULL
LCL	NULL
Anti-CD3	NULL
€	NULL
IL-2	NULL
mRNA	NULL
€	NULL
IL-10	NULL
mRNA	NULL
<	NULL
<	NULL
--	NULL
IFN-y	NULL
mRNA	NULL
<	NULL
L	NULL
TNF-a	NULL
mRNA	NULL
m	NULL
«	NULL
--	NULL
@	NULL
*	NULL
DPCP	NULL
--	NULL
Figure	NULL
2	NULL
.	NULL

Kinetics	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
mRNA	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
lymphoblasts	NULL
from	NULL
two	NULL
different	NULL
donors	NULL
were	NULL
separately	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
or	NULL
LCL	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
time-points	NULL
indicated	NULL
,	NULL
pooled	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
size-fractionated	NULL
in	NULL
formaldehyde-agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
*°P-labelled	NULL
fragment	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
GAPDH	NULL
cDNA	NULL
probes	NULL
.	NULL

used	NULL
in	NULL
fivefold	NULL
dilutions	NULL
starting	NULL
from	NULL
0-2	NULL
ng	NULL
(	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-6	NULL
and	NULL
TNF-q	NULL
)	NULL
or	NULL
5-0	NULL
ng	NULL
(	NULL
for	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
B	NULL
;	NULL
,	NULL
-microglo-bulin	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
multi-specific	NULL
plasmids	NULL
,	NULL
their	NULL
use	NULL
in	NULL
cDNA	NULL
quantification	NULL
and	NULL
the	NULL
primer	NULL
sequences	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
A	NULL
similar	NULL
quantification	NULL
of	NULL
B	NULL
,	NULL
-microglobulin	NULL
expression	NULL
was	NULL
used	NULL
to	NULL
correct	NULL
the	NULL
variation	NULL
in	NULL
the	NULL
cDNA	NULL
synthesis	NULL
.	NULL

In	NULL
order	NULL
to	NULL
optimize	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
amplification	NULL
in	NULL
the	NULL
first	NULL
round	NULL
of	NULL
PCR	NULL
,	NULL
all	NULL
the	NULL
cDNA	NULL
samples	NULL
were	NULL
diluted	NULL
1-100	NULL
for	NULL
the	NULL
amplification	NULL
of	NULL
B	NULL
,	NULL
-microglobulin-specific	NULL
pri-mers	NULL
.	NULL

Similarly	NULL
,	NULL
1-hr	NULL
and	NULL
3-hr	NULL
cDNA	NULL
samples	NULL
were	NULL
diluted	NULL
1-100	NULL
for	NULL
the	NULL
amplification	NULL
with	NULL
IFN-y-	NULL
and	NULL
IL-10-specific	NULL
primer	NULL
pairs	NULL
,	NULL
whereas	NULL
RT-PCR	NULL
for	NULL
other	NULL
cytokines	NULL
was	NULL
done	NULL
in	NULL
undiluted	NULL
cDNA	NULL
samples	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
pooled	NULL
cell	NULL
samples	NULL
obtained	NULL
from	NULL
two	NULL
or	NULL
three	NULL
individual	NULL
blood	NULL
donors	NULL
using	NULL
the	NULL
guanidinium	NULL
isothiocyanate-caesium	NULL
chloride	NULL
method	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Equal	NULL
amounts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
of	NULL
the	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
size-fractionated	NULL
in	NULL
1	NULL
%	NULL
formaldehyde-agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond	NULL
,	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blotting	NULL
analysis	NULL
with	NULL
*°P-labelled	NULL
cDNA	NULL
probes	NULL
.	NULL

The	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
were	NULL
human	NULL
IL-2	NULL
,	NULL
``	NULL
IL-4	NULL
,	NULL
IL-6	NULL
,	NULL
IL-10	NULL
(	NULL
obtained	NULL
from	NULL
DNAX	NULL
Laboratories	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
IFN-y	NULL
``	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
ATCC	NULL
)	NULL
.	NULL

NFATcl	NULL
(	NULL
NFATc	NULL
)	NULL
,	NULL
NFATc2	NULL
(	NULL
NFATp	NULL
)	NULL
,	NULL
NFATc3	NULL
(	NULL
NFAT4	NULL
)	NULL
cDNAs	NULL
``	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
G.	NULL
Grabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
c-jun	NULL
,	NULL
and	NULL
c-fos	NULL
genes	NULL
were	NULL
obtained	NULL
from	NULL
Dr	NULL
R.	NULL
Bravo	NULL
(	NULL
Bristol-Myers	NULL
Squib	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

For	NULL
controlling	NULL
equal	NULL
RNA	NULL
loading	NULL
,	NULL
ethidium	NULL
bromide	NULL
staining	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
with	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
and	NULL
B-actin'*	NULL
'	NULL
cDNA	NULL
probes	NULL
were	NULL
used	NULL
in	NULL
the	NULL
assays	NULL
.	NULL

Cytokine	NULL
determinations	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
levels	NULL
in	NULL
cell	NULL
culture	NULL
supernatants	NULL
were	NULL
measured	NULL
using	NULL
enzyme-linked	NULL
immuno-sorbent	NULL
asay	NULL
(	NULL
ELISA	NULL
)	NULL
kits	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Cycloheximide	NULL
and	NULL
cyclosporin	NULL
A	NULL
treatment	NULL
To	NULL
inhibit	NULL
cellular	NULL
protein	NULL
synthesis	NULL
during	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
;	NULL
Sigma	NULL
)	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
stimulation	NULL
and	NULL
the	NULL
inhibitor	NULL
was	NULL
kept	NULL
present	NULL
throughout	NULL
the	NULL
experiment	NULL
.	NULL

This	NULL
concentration	NULL
of	NULL
CHX	NULL
is	NULL
sufficient	NULL
to	NULL
block	NULL
fully	NULL
all	NULL
protein	NULL
synthesis	NULL
in	NULL
leucocytes	NULL
.	NULL

``	NULL
°	NULL
Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
;	NULL
Sandoz	NULL
Pharma	NULL
Ag	NULL
,	NULL
Basel	NULL
,	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
r	NULL
TTT	NULL
]	NULL
10000	NULL
r	NULL
run	NULL
T	NULL
1000	NULL
ror	NULL
rm	NULL
]	NULL
100	NULL
Cytokine	NULL
concentration	NULL
(	NULL
pg/ml	NULL
)	NULL
experiments	NULL
.	NULL

Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
353	NULL
LCL	NULL
E	NULL
Anti-CD3	NULL
-	NULL
IFN-y	NULL
R	NULL
TNF-a	NULL
E	NULL
m	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
Stimulation	NULL
time	NULL
(	NULL
hr	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

Kinetics	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
protein	NULL
production	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
culture	NULL
supernatants	NULL
from	NULL
LCL-	NULL
and	NULL
anti-CD3-stimulated	NULL
T	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Cytokine	NULL
levels	NULL
were	NULL
determined	NULL
using	NULL
commercial	NULL
ELISA	NULL
kits	NULL
,	NULL
and	NULL
the	NULL
kinetics	NULL
and	NULL
quantity	NULL
of	NULL
cytokine	NULL
secretion	NULL
are	NULL
shown	NULL
.	NULL

Each	NULL
time-point	NULL
represents	NULL
the	NULL
mean	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
of	NULL
three	NULL
separate	NULL
cytokine	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
-	NULL
anti	NULL
Switzerland	NULL
)	NULL
was	NULL
used	NULL
at	NULL
10	NULL
ug/ml	NULL
to	NULL
block	NULL
the	NULL
calcineurin-dependent	NULL
activation	NULL
pathways	NULL
.	NULL
``	NULL

RESULTS	NULL
Quantitative	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
We	NULL
concentrated	NULL
on	NULL
analysis	NULL
of	NULL
the	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
at	NULL
early	NULL
times	NULL
after	NULL
T-cell	NULL
stimulation	NULL
.	NULL

Quantitative	NULL
RT-PCR	NULL
analyses	NULL
carried	NULL
out	NULL
in	NULL
three	NULL
separate	NULL
experiments	NULL
revealed	NULL
a	NULL
reproducible	NULL
pattern	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
,	NULL
detectable	NULL
levels	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
mRNA	NULL
were	NULL
seen	NULL
by	NULL
RT-PCR	NULL
.	NULL

One	NULL
hour	NULL
after	NULL
anti-CD3-stimulation	NULL
,	NULL
a	NULL
several	NULL
hundred-fold	NULL
increase	NULL
in	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
mRNA	NULL
levels	NULL
was	NULL
observed	NULL
,	NULL
whereas	NULL
the	NULL
up-regulation	NULL
of	NULL
IL-4	NULL
and	NULL
IL-10	NULL
gene	NULL
expression	NULL
was	NULL
more	NULL
modest	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

At	NULL
3	NULL
hr	NULL
after	NULL
anti-CD3	NULL
treatment	NULL
the	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
was	NULL
further	NULL
up-regulated	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
TNF-	NULL
«	NULL
whos	NULL
.	NULL

mRNA	NULL
expression	NULL
remained	NULL
similar	NULL
to	NULL
that	NULL
recorded	NULL
at	NULL
1	NULL
hr	NULL
.	NULL

No	NULL
basal	NULL
or	NULL
inducible	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
was	NULL
seen	NULL
.	NULL

Kinetics	NULL
of	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
and	NULL
protein	NULL
production	NULL
in	NULL
T	NULL
cells	NULL
To	NULL
have	NULL
a	NULL
better	NULL
insight	NULL
into	NULL
the	NULL
kinetics	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
we	NULL
analysed	NULL
the	NULL
time-course	NULL
of	NULL
both	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
CD3-stimulated	NULL
and	NULL
LCL-stimulated	NULL
cells	NULL
Comparison	NULL
of	NULL
LCL-stimulated	NULL
cells	NULL
to	NULL
those	NULL
of	NULL
anti-CD3-stimulated	NULL
cells	NULL
revealed	NULL
differences	NULL
in	NULL
the	NULL
kinetics	NULL
of	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
.	NULL

Both	NULL
inducers	NULL
readily	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
cytokine	NULL
genes	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
of	NULL
LCL-stimulated	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
for	NULL
IL-2	NULL
and	NULL
especially	NULL
for	NULL
IL-10	NULL
were	NULL
found	NULL
at	NULL
later	NULL
times	NULL
after	NULL
the	NULL
stimulation	NULL
,	NULL
at	NULL
3	NULL
hr	NULL
and	NULL
16	NULL
hr	NULL
,	NULL
respectively	NULL
.	NULL

IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
mRNA	NULL
expression	NULL
,	NULL
instead	NULL
,	NULL
peaked	NULL
at	NULL
1	NULL
hr	NULL
after	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
anti-CD3-stimulated	NULL
cells	NULL
IL-2	NULL
expression	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
LCL-stimulated	NULL
cells	NULL
.	NULL

IL-10	NULL
mRNA	NULL
expression	NULL
peaked	NULL
at	NULL
the	NULL
much	NULL
earlier	NULL
time-point	NULL
of	NULL
3	NULL
hr	NULL
,	NULL
as	NULL
did	NULL
IFN-y	NULL
mRNA	NULL
expression	NULL
.	NULL

mRNA	NULL
expression	NULL
was	NULL
very	NULL
fast	NULL
and	NULL
showed	NULL
almost	NULL
identical	NULL
kinetics	NULL
of	NULL
expression	NULL
with	NULL
both	NULL
stimulators	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

IL-4	NULL
or	NULL
IL-6	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
visualized	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
Northern	NULL
blot	NULL
data	NULL
were	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
quantitative	NULL
RT-PCR	NULL
analysis	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Next	NULL
we	NULL
analysed	NULL
T-cell	NULL
cytokine	NULL
production	NULL
using	NULL
quantitative	NULL
ELISA	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
secretion	NULL
of	NULL
IFN-y	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
IL-2	NULL
was	NULL
seen	NULL
already	NULL
at	NULL
1	NULL
hr	NULL
after	NULL
anti-CD3	NULL
antibody	NULL
or	NULL
LCL	NULL
stimulation	NULL
.	NULL

There	NULL
was	NULL
a	NULL
clear	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
these	NULL
cytokines	NULL
and	NULL
very	NULL
354	NULL
T.	NULL
Sareneva	NULL
et	NULL
al	NULL
.	NULL

high	NULL
levels	NULL
were	NULL
reached	NULL
within	NULL
6	NULL
hr	NULL
after	NULL
stimulation	NULL
.	NULL

IL-4	NULL
and	NULL
IL-10	NULL
secretion	NULL
was	NULL
also	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
but	NULL
their	NULL
amounts	NULL
were	NULL
up	NULL
to	NULL
100-1000-fold	NULL
lower	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
other	NULL
cytokines	NULL
.	NULL

It	NULL
is	NULL
also	NULL
noteworthy	NULL
that	NULL
IL-10	NULL
production	NULL
continued	NULL
to	NULL
increase	NULL
throughout	NULL
the	NULL
study	NULL
period	NULL
,	NULL
suggesting	NULL
a	NULL
slower	NULL
kinetics	NULL
of	NULL
synthesis	NULL
and	NULL
secretion	NULL
.	NULL

Cytokine	NULL
gene	NULL
expression	NULL
is	NULL
activated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
As	NULL
there	NULL
were	NULL
clear	NULL
differences	NULL
in	NULL
the	NULL
kinetics	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
analyse	NULL
whether	NULL
these	NULL
genes	NULL
were	NULL
direct	NULL
targets	NULL
for	NULL
T-cell	NULL
receptor-activated	NULL
transcriptional	NULL
systems	NULL
.	NULL

We	NULL
treated	NULL
T	NULL
cells	NULL
with	NULL
CHX	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
30	NULL
min	NULL
before	NULL
anti-CD3	NULL
antibody	NULL
stimulation	NULL
or	NULL
left	NULL
them	NULL
untreated	NULL
and	NULL
collected	NULL
cells	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3hr	NULL
after	NULL
the	NULL
stimulation	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
revealed	NULL
that	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
almost	NULL
completely	NULL
blocked	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
whereas	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
mRNA	NULL
expression	NULL
appeared	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
all	NULL
the	NULL
other	NULL
genes	NULL
but	NULL
IL-2	NULL
are	NULL
under	NULL
direct	NULL
transcriptional	NULL
control	NULL
of	NULL
T-cell	NULL
receptor-activated	NULL
transcriptional	NULL
systems	NULL
.	NULL

The	NULL
gene	NULL
for	NULL
TNF-	NULL
«	NULL
behaved	NULL
differently	NULL
from	NULL
the	NULL
other	NULL
genes	NULL
since	NULL
TNF-	NULL
«	NULL
mRNA	NULL
levels	NULL
appeared	NULL
to	NULL
be	NULL
much	NULL
higher	NULL
,	NULL
especially	NULL
at	NULL
2	NULL
and	NULL
3	NULL
hr	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
as	NULL
compared	NULL
to	NULL
untreated	NULL
cells	NULL
.	NULL

This	NULL
may	NULL
result	NULL
from	NULL
an	NULL
mRNA	NULL
stabilizing	NULL
effect	NULL
of	NULL
CHX	NULL
that	NULL
has	NULL
been	NULL
suggested	NULL
previously	NULL
.	NULL
``	NULL

AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
is	NULL
enhanced	NULL
by	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcriptional	NULL
systems	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
take	NULL
part	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
several	NULL
T-cell	NULL
cytokine	NULL
genes	NULL
.	NULL

At	NULL
least	NULL
IL-2	NULL
,	NULL
IL-4	NULL
and	NULL
TNF-4	NULL
gene	NULL
promoters	NULL
contain	NULL
elements	NULL
that	NULL
bind	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factors	NULL
.	NULL
'	NULL

>	NULL
*	NULL
``	NULL
Therefore	NULL
,	NULL
we	NULL
analysed	NULL
whether	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
was	NULL
activated	NULL
by	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

We	NULL
stimulated	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
and	NULL
anti-CD3	NULL
antibodies	NULL
and	NULL
analysed	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
,	NULL
c-fos	NULL
(	NULL
AP-1	NULL
proteins	NULL
)	NULL
,	NULL
and	NULL
NFAT	NULL
genes	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNA	NULL
were	NULL
strongly	NULL
up-regulated	NULL
already	NULL
at	NULL
1	NULL
hr	NULL
with	NULL
both	NULL
inducers	NULL
and	NULL
their	NULL
levels	NULL
started	NULL
to	NULL
decrease	NULL
thereafter	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Anti-CD3	NULL
stimulation	NULL
was	NULL
a	NULL
better	NULL
inducer	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
than	NULL
PMA	NULL
whereas	NULL
PMA	NULL
induced	NULL
c-jun	NULL
gene	NULL
Time	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
hr	NULL
)	NULL
Anti-CD3	NULL
-o	NULL
0	NULL
-	NULL
+	NULL
+	NULL
CHX	NULL
IL-2	NULL
mRNA	NULL
IL-10	NULL
mRNA	NULL
IFN-y	NULL
mRNA	NULL
Figure	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
on	NULL
IL-2	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
gene	NULL
expression	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
hr	NULL
after	NULL
the	NULL
stimulation	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
mRNA	NULL
expression	NULL
levels	NULL
were	NULL
analysed	NULL
by	NULL
Northern	NULL
blotting	NULL
with	NULL
*P-labelled	NULL
cytokine-specific	NULL
cDNA	NULL
probes	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
355	NULL
PMA	NULL
Anti-CD3	NULL
,	NULL
TNF-a	NULL
*A	NULL
C-	NULL
mRNA	NULL
snmp	NULL
c-jun	NULL
C-	NULL
mRNA	NULL
c-fos	NULL
C-	NULL
mRNA	NULL
PMA	NULL
Anti-CD3	NULL
O-l	NULL
10	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
-	NULL
O-Il	NULL
(	NULL
Hr	NULL
)	NULL
NFATe1	NULL
gag	NULL
wa	NULL
C-	NULL
mRNA	NULL
Coombs	NULL
.	NULL

me	NULL
t	NULL
rough	NULL
NFATe2	NULL
e	NULL
<	NULL
--	NULL
on	NULL
's	NULL
€	NULL
NFATc3	NULL
mRNA	NULL
285	NULL
RNA	NULL
188	NULL
RNA	NULL
Figure	NULL
5	NULL
.	NULL

Expression	NULL
kinetics	NULL
of	NULL
IFN-y	NULL
,	NULL
TNF-4	NULL
,	NULL
c-jun	NULL
,	NULL
c-fos	NULL
and	NULL
NFAT	NULL
genes	NULL
in	NULL
anti-CD3-	NULL
and	NULL
PMA-stimulated	NULL
T	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
stimulated	NULL
T	NULL
cells	NULL
at	NULL
the	NULL
time-points	NULL
indicated	NULL
,	NULL
and	NULL
steady-state	NULL
IFN-y	NULL
,	NULL
TNF-4	NULL
,	NULL
c-jun	NULL
,	NULL
c-fos	NULL
,	NULL
NFATp	NULL
,	NULL
NFATc	NULL
and	NULL
NFAT3	NULL
mRNA	NULL
levels	NULL
were	NULL
analysed	NULL
by	NULL
Northern	NULL
blotting	NULL
using	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
hybridized	NULL
with	NULL
the	NULL
respective	NULL
cDNA	NULL
probes	NULL
.	NULL

more	NULL
efficiently	NULL
compared	NULL
to	NULL
anti-CD3	NULL
antibodies	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
NFAT	NULL
mRNA	NULL
expression	NULL
revealed	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
NFATc2	NULL
and	NULL
NFAc3	NULL
were	NULL
relatively	NULL
high	NULL
,	NULL
whereas	NULL
the	NULL
mRNA	NULL
level	NULL
for	NULL
NFATcl	NULL
was	NULL
hardly	NULL
detectable	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PMA	NULL
resulted	NULL
in	NULL
a	NULL
modest	NULL
up-regulation	NULL
of	NULL
all	NULL
analysed	NULL
NFAT	NULL
genes	NULL
.	NULL

Anti-CD3	NULL
stimulation	NULL
,	NULL
instead	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
very	NULL
strong	NULL
up-regulation	NULL
of	NULL
NFATcl	NULL
gene	NULL
expression	NULL
.	NULL

Neither	NULL
NFATc2	NULL
nor	NULL
NFATc3	NULL
gene	NULL
expression	NULL
was	NULL
activated	NULL
,	NULL
rather	NULL
there	NULL
was	NULL
a	NULL
clearly	NULL
detectable	NULL
decrease	NULL
in	NULL
-	NULL
NFATc3	NULL
mRNA	NULL
-	NULL
expression	NULL
-	NULL
in	NULL
-	NULL
anti-CD3-stimulated	NULL
cells	NULL
2-3	NULL
hr	NULL
after	NULL
the	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Next	NULL
we	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
,	NULL
a	NULL
known	NULL
inhibitor	NULL
of	NULL
the	NULL
calcineurin/NFAT	NULL
pathway	NULL
and	NULL
an	NULL
inhibitor	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
``	NULL
on	NULL
PMA-	NULL
and	NULL
anti-CD3	NULL
antibody-stimulated	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
gene	NULL
expression	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
modest	NULL
induction	NULL
of	NULL
IFN-y	NULL
gene	NULL
expression	NULL
,	NULL
whereas	NULL
no	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
was	NULL
seen	NULL
.	NULL

PMA-induced	NULL
IFN-y	NULL
gene	NULL
expression	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

Anti-CD3	NULL
antibody	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
up-regulation	NULL
of	NULL
both	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
gene	NULL
expression	NULL
.	NULL

CsA	NULL
very	NULL
efficiently	NULL
blocked	NULL
this	NULL
up-regulation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Since	NULL
anti-CD3	NULL
antibody-induced	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
expression	NULL
was	NULL
inhibited	NULL
by	NULL
CsA	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
NFAT-mediated	NULL
pathway	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
.	NULL

DISCUSSION	NULL
Stimulation	NULL
of	NULL
T-cell	NULL
receptor	NULL
by	NULL
specific	NULL
antibodies	NULL
has	NULL
been	NULL
an	NULL
important	NULL
experimental	NULL
approach	NULL
in	NULL
understanding	NULL
the	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
gene	NULL
activation	NULL
mechanisms	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
'	NULL
In	NULL
the	NULL
present	NULL
work	NULL
we	NULL
used	NULL
this	NULL
approach	NULL
to	NULL
analyse	NULL
the	NULL
quality	NULL
and	NULL
quantity	NULL
of	NULL
cytokines	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
obtained	NULL
from	NULL
PBMC	NULL
after	NULL
removal	NULL
of	NULL
adherent	NULL
cells	NULL
.	NULL

We	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
with	NULL
anti-CD3	NULL
antibodies	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
the	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
specific	NULL
antigen	NULL
.	NULL

Within	NULL
4	NULL
weeks	NULL
there	NULL
was	NULL
a	NULL
clear	NULL
overgrowth	NULL
of	NULL
T	NULL
cells	NULL
carrying	NULL
CD8	NULL
antigen	NULL
markers	NULL
.	NULL

We	NULL
concentrated	NULL
on	NULL
the	NULL
analysis	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
profiles	NULL
at	NULL
early	NULL
times	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
including	NULL
IL-2	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
were	NULL
rapidly	NULL
turned	NULL
on	NULL
by	NULL
anti-CD3	NULL
stimulation	NULL
suggesting	NULL
that	NULL
they	NULL
are	NULL
direct	NULL
target	NULL
genes	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

This	NULL
concept	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
at	NULL
least	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
«	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
were	NULL
also	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
.	NULL

IL-2	NULL
gene	NULL
expression	NULL
,	NULL
instead	NULL
,	NULL
seemed	NULL
in	NULL
a	NULL
major	NULL
part	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
.	NULL

There	NULL
were	NULL
further	NULL
certain	NULL
differences	NULL
in	NULL
the	NULL
kinetics	NULL
of	NULL
activation	NULL
of	NULL
different	NULL
genes	NULL
.	NULL

TNF-u	NULL
gene	NULL
expression	NULL
was	NULL
turned	NULL
on	NULL
very	NULL
rapidly	NULL
and	NULL
the	NULL
peak	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
were	NULL
observed	NULL
1	NULL
hr	NULL
after	NULL
stimulation	NULL
.	NULL

Higher	NULL
TNF-	NULL
«	NULL
mRNA	NULL
levels	NULL
were	NULL
seen	NULL
in	NULL
CHX-treated	NULL
cells	NULL
,	NULL
which	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
stabilizing	NULL
effect	NULL
of	NULL
CHX	NULL
on	NULL
TNF-	NULL
«	NULL
mRNA	NULL
.	NULL
``	NULL

The	NULL
kinetics	NULL
of	NULL
expression	NULL
of	NULL
other	NULL
cytokine	NULL
mRNA	NULL
was	NULL
different	NULL
from	NULL
that	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
peak	NULL
levels	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
expression	NULL
were	NULL
observed	NULL
3	NULL
hr	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
a	NULL
prolonged	NULL
356	NULL
T.	NULL
Sareneva	NULL
et	NULL
al	NULL
.	NULL

-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
PMA	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
Anti-CD3	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Cyclosporin	NULL
A	NULL
<	NULL
IL-2	NULL
mRNA	NULL
IFN-WP	NULL
|	NULL
<	NULL
-	NULL
mona	NULL
see	NULL
asl	NULL
B-actin	NULL
<	NULL
-	NULL
lank	NULL
Figure	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
CsA	NULL
on	NULL
IFN-y	NULL
and	NULL
TNF-4	NULL
«	NULL
gene	NULL
expression	NULL
in	NULL
PMA-	NULL
and	NULL
anti-CD3-stimulated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
CsA	NULL
was	NULL
added	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
stimulation	NULL
and	NULL
was	NULL
kept	NULL
present	NULL
throughout	NULL
the	NULL
experiment	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
3	NULL
hr	NULL
with	NULL
PMA	NULL
or	NULL
anti-CD3	NULL
,	NULL
and	NULL
collected	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
analysed	NULL
by	NULL
Northern	NULL
blotting	NULL
using	NULL
probes	NULL
specific	NULL
for	NULL
IFN-y	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
B-actin	NULL
.	NULL

transcriptional	NULL
activation	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
longer	NULL
half-life	NULL
of	NULL
these	NULL
mRNA	NULL
compared	NULL
to	NULL
TNF-	NULL
«	NULL
mRNA	NULL
or	NULL
alternatively	NULL
that	NULL
some	NULL
newly	NULL
synthesized	NULL
transcription	NULL
factors	NULL
would	NULL
further	NULL
enhance	NULL
the	NULL
transcription	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
.	NULL

Efficient	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
clearly	NULL
dependent	NULL
on	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
,	NULL
since	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
only	NULL
minor	NULL
amounts	NULL
of	NULL
IL-2	NULL
mRNA	NULL
were	NULL
seen	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Although	NULL
genes	NULL
for	NULL
IL-10	NULL
and	NULL
IFN-y	NULL
were	NULL
also	NULL
turned	NULL
on	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
there	NULL
was	NULL
a	NULL
further	NULL
accumulation	NULL
of	NULL
these	NULL
mRNA	NULL
(	NULL
especially	NULL
IFN-y	NULL
)	NULL
at	NULL
later	NULL
time-points	NULL
(	NULL
Figs	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
a	NULL
positive	NULL
feedback	NULL
system	NULL
provided	NULL
either	NULL
by	NULL
newly	NULL
synthesized	NULL
cytokines	NULL
or	NULL
by	NULL
enhanced	NULL
gene	NULL
expression	NULL
and	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factors	NULL
.	NULL

Neither	NULL
IFN-y	NULL
,	NULL
nor	NULL
TNF-	NULL
«	NULL
appeared	NULL
to	NULL
take	NULL
part	NULL
in	NULL
activating	NULL
their	NULL
own	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
pure	NULL
preparations	NULL
of	NULL
IFN-y	NULL
or	NULL
TNF-4	NULL
did	NULL
not	NULL
result	NULL
in	NULL
enhanced	NULL
IFN-y	NULL
mRNA	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
however	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
enhancing	NULL
IFN-y	NULL
production	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
and	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
its	NULL
role	NULL
as	NULL
a	NULL
factor	NULL
further	NULL
enhancing	NULL
IFN-y	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
early	NULL
hours	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
is	NULL
further	NULL
enhancing	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
IFN-y	NULL
and	NULL
other	NULL
cytokines	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
more	NULL
directly	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
,	NULL
c-fos	NULL
,	NULL
NFATcl	NULL
,	NULL
NFATc2	NULL
and	NULL
NFATc3	NULL
genes	NULL
.	NULL

NFAT/AP-1	NULL
transcriptional	NULL
systems	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
T-cell	NULL
cytokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
IL-4	NULL
and	NULL
and	NULL
are	NULL
possibly	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IFN-y	NULL
gene	NULL
.	NULL
``	NULL

There	NULL
was	NULL
a	NULL
very	NULL
strong	NULL
and	NULL
fast	NULL
up-regulation	NULL
of	NULL
both	NULL
c-jun	NULL
and	NULL
c-fos	NULL
gene	NULL
expression	NULL
by	NULL
anti-CD3	NULL
antibody	NULL
stimulation	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
up-regulation	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
gene	NULL
expression	NULL
,	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
was	NULL
also	NULL
enhanced	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Kinetically	NULL
the	NULL
enhanced	NULL
c-jun/c-fos	NULL
gene	NULL
expression	NULL
matched	NULL
the	NULL
kinetics	NULL
of	NULL
enhanced	NULL
expression	NULL
of	NULL
IL-2	NULL
,	NULL
IL-10	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
,	NULL
which	NULL
were	NULL
seen	NULL
3	NULL
hr	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

NFATcl	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
was	NULL
also	NULL
strongly	NULL
enhanced	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

Practically	NULL
no	NULL
induction	NULL
of	NULL
NFATc2	NULL
or	NULL
NFATc3	NULL
genes	NULL
was	NULL
seen	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
obtained	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
``	NULL
or	NULL
anti-CD16-stimulated	NULL
NK	NULL
cells	NULL
.	NULL

``	NULL
°	NULL
Further	NULL
evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
NFAT	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
obtained	NULL
from	NULL
experiments	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
which	NULL
clearly	NULL
demonstrated	NULL
a	NULL
significant	NULL
inhibition	NULL
of	NULL
anti-CD3	NULL
antibody-induced	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
not	NULL
only	NULL
activates	NULL
several	NULL
different	NULL
transcriptional	NULL
systems	NULL
but	NULL
also	NULL
enhances	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factors	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
events	NULL
are	NULL
apparently	NULL
important	NULL
components	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
magnitude	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
may	NULL
be	NULL
the	NULL
case	NULL
,	NULL
especially	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
which	NULL
occurred	NULL
efficiently	NULL
only	NULL
if	NULL
the	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
was	NULL
taking	NULL
place	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
non-antigenic	NULL
stimulation	NULL
to	NULL
produce	NULL
a	NULL
number	NULL
of	NULL
different	NULL
cytokines	NULL
.	NULL

The	NULL
main	NULL
cytokines	NULL
produced	NULL
were	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
production	NULL
of	NULL
IL-4	NULL
was	NULL
very	NULL
low	NULL
,	NULL
whereas	NULL
IL-10	NULL
was	NULL
produced	NULL
in	NULL
reasonable	NULL
amounts	NULL
.	NULL

However	NULL
,	NULL
the	NULL
predominant	NULL
cytokine	NULL
produced	NULL
was	NULL
IFN-y	NULL
which	NULL
indicates	NULL
a	NULL
Thl-like	NULL
cytokine	NULL
profile	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
initially	NULL
obtained	NULL
by	NULL
IL-2/anti-CD3	NULL
stimulation	NULL
,	NULL
which	NULL
may	NULL
have	NULL
driven	NULL
them	NULL
towards	NULL
a	NULL
Th1-like	NULL
cellular	NULL
differentiation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Jenny	NULL
and	NULL
Antti	NULL
Wihuri	NULL
Foundation	NULL
,	NULL
the	NULL
Finnish	NULL
Foundation	NULL
for	NULL
Research	NULL
on	NULL
Viral	NULL
Diseases	NULL
,	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
the	NULL
Academy	NULL
of	NULL
Finland	NULL
,	NULL
the	NULL
Finnish	NULL
Cancer	NULL
Foundations	NULL
,	NULL
the	NULL
Paulo	NULL
Foundation	NULL
and	NULL
the	NULL
Technology	NULL
Development	NULL
Centre	NULL
of	NULL
Finland	NULL
(	NULL
TEKES	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Heprick	NULL
S.M	NULL
.	NULL

&	NULL
Eipetman	NULL
FJ	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

In	NULL
:	NULL
Fundamental	NULL
Immunology	NULL
(	NULL
ed	NULL
.	NULL

W.	NULL
E.	NULL
Paul	NULL
)	NULL
,	NULL
3rd	NULL
edn	NULL
,	NULL
pp	NULL
.	NULL

383-420	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

2	NULL
.	NULL

MosmanN	NULL
TR	NULL
.	NULL

,	NULL
CHerwinsk1	NULL
H.	NULL
,	NULL
Bonp	NULL
M.W	NULL
.	NULL

,	NULL
GiEpLm	NULL
M.A	NULL
.	NULL

&	NULL
CorFMAN	NULL
R.L	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Two	NULL
types	NULL
of	NULL
murine	NULL
helper	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

I	NULL
.	NULL

Definition	NULL
according	NULL
to	NULL
profiles	NULL
of	NULL
lymphokine	NULL
activities	NULL
and	NULL
secreted	NULL
proteins	NULL
.	NULL

J	NULL
Immunol	NULL
136	NULL
,	NULL
2348	NULL
.	NULL

3	NULL
.	NULL

CHErwinskIt	NULL
H.M.	NULL
,	NULL
Schumacher	NULL
J.H	NULL
.	NULL

,	NULL
Brown	NULL
K.D	NULL
.	NULL

&	NULL
MosmanN	NULL
T.R	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Two	NULL
types	NULL
of	NULL
mouse	NULL
helper	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

III	NULL
.	NULL

Further	NULL
differences	NULL
in	NULL
lymphokine	NULL
synthesis	NULL
between	NULL
Thl	NULL
and	NULL
Th2	NULL
clones	NULL
revealed	NULL
by	NULL
RNA	NULL
hybridization	NULL
,	NULL
functionally	NULL
monospecific	NULL
bioas-says	NULL
,	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
166	NULL
,	NULL
1229	NULL
.	NULL

4	NULL
.	NULL

Det	NULL
PretE	NULL
G.F.	NULL
,	NULL
pe	NULL
CARLE	NULL
M.	NULL
,	NULL
MastROMAURO	NULL
C.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Purified	NULL
protein	NULL
derivative	NULL
of	NULL
Mycobacterium	NULL
tuberculosis	NULL
and	NULL
excretory-secretory	NULL
antigen	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Toxocara	NULL
canis	NULL
expand	NULL
in	NULL
vitro	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18.	NULL
.	NULL

Seper	NULL
RA	NULL
.	NULL

,	NULL
BouLray	NULL
J.-L.	NULL
,	NULL
FINKELMAN	NULL
F.	NULL
Cytokine	NULL
gene	NULL
expression	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
stable	NULL
and	NULL
opposite	NULL
(	NULL
type	NULL
1	NULL
T	NULL
helper	NULL
or	NULL
type	NULL
2	NULL
T	NULL
helper	NULL
)	NULL
profile	NULL
of	NULL
cytokine	NULL
production	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88	NULL
,	NULL
346.	NULL
.	NULL

Mosman	NULL
TR	NULL
.	NULL

&	NULL
Sap	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
expanding	NULL
universe	NULL
of	NULL
T-cell	NULL
subsets	NULL
:	NULL
Th1	NULL
,	NULL
Th2	NULL
and	NULL
more	NULL
.	NULL

Immunol	NULL
Today	NULL
17	NULL
,	NULL
138.	NULL
.	NULL

ABBAS	NULL
A.K	NULL
.	NULL

,	NULL
MurpHuy	NULL
K.	NULL
&	NULL
Suer	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Functional	NULL
diversity	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
383	NULL
,	NULL
787.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
CD8	NULL
+T	NULL
cells	NULL
can	NULL
be	NULL
primed	NULL
in	NULL
vitro	NULL
to	NULL
produce	NULL
IL-4	NULL
.	NULL

J	NULL
Immunol	NULL
148	NULL
,	NULL
1652.	NULL
.	NULL

CrRort	NULL
M.	NULL
,	NULL
CartTER	NULL
L.	NULL
,	NULL
Swam	NULL
S.L	NULL
.	NULL

&	NULL
Dutton	NULL
RW	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Generation	NULL
of	NULL
polarized	NULL
antigen-specific	NULL
CD8	NULL
effector	NULL
populations	NULL
:	NULL
reciprocal	NULL
action	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-4	NULL
and	NULL
IL-12	NULL
in	NULL
promoting	NULL
type	NULL
2	NULL
vs.	NULL
type	NULL
1	NULL
cytokine	NULL
profiles	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180	NULL
,	NULL
1715.	NULL
.	NULL

TougH	NULL
D.F	NULL
.	NULL

,	NULL
Borrow	NULL
P.	NULL
&	NULL
SpreNT	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Induction	NULL
of	NULL
bystander	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
viruses	NULL
and	NULL
type	NULL
I	NULL
interferon	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
272	NULL
,	NULL
1947	NULL
.	NULL

CANTRELL	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
14	NULL
,	NULL
259	NULL
.	NULL

CRABTREE	NULL
G.R	NULL
.	NULL

&	NULL
CuipstonE	NULL
N.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
63	NULL
,	NULL
1045	NULL
.	NULL

Rao	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
NFAT	NULL
p	NULL
,	NULL
a	NULL
cyclosporin-sensitive	NULL
transcription	NULL
factor	NULL
implicated	NULL
in	NULL
cytokine	NULL
gene	NULL
induction	NULL
.	NULL

J	NULL
Leukocyte	NULL
Bio	NULL
!	NULL

57	NULL
,	NULL
536	NULL
.	NULL

BovaBouLa	NULL
M.	NULL
,	NULL
Lrcoux	NULL
P.	NULL
,	NULL
PessEGue	NULL
B.	NULL
et	NULL
al	NULL
(	NULL
1992	NULL
)	NULL
Standardization	NULL
of	NULL
mRNA	NULL
titration	NULL
using	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction	NULL
method	NULL
involving	NULL
co-amplification	NULL
with	NULL
a	NULL
multispecific	NULL
internal	NULL
control	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
267	NULL
,	NULL
21	NULL
830.	NULL
.	NULL

CHirGwin	NULL
J.M	NULL
.	NULL

,	NULL
PrzysByta	NULL
AE	NULL
.	NULL

,	NULL
MacDbonaLp	NULL
R.J.	NULL
&	NULL
RutrER	NULL
W.J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18	NULL
,	NULL
5294.	NULL
.	NULL

Guisin	NULL
V.	NULL
,	NULL
CrKvenJakov	NULL
R.	NULL
&	NULL
Byus	NULL
C.	NULL
(	NULL
1974	NULL
)	NULL
Ribonucleic	NULL
acid	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
.	NULL

Biochemistry	NULL
13	NULL
,	NULL
2633	NULL
.	NULL

Taniguce	NULL
T.	NULL
,	NULL
Matsu	NULL
H.	NULL
,	NULL
FuKita	NULL
T.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
cDNA	NULL
for	NULL
human	NULL
interleukin-2	NULL
.	NULL

Nature	NULL
302	NULL
,	NULL
305	NULL
.	NULL

SarenEva	NULL
T.	NULL
,	NULL
PIRHONEN	NULL
J.	NULL
,	NULL
CANTELL	NULL
K.	NULL
,	NULL
KALKKINEN	NULL
N.	NULL
&	NULL
Jurkunen	NULL
I	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Effect	NULL
of	NULL
N-linked	NULL
glycosylation	NULL
in	NULL
the	NULL
synthesis	NULL
,	NULL
dimerization	NULL
and	NULL
secretion	NULL
of	NULL
recombinant	NULL
human	NULL
IFN-y	NULL
.	NULL

Biochem	NULL
J	NULL
303	NULL
,	NULL
841	NULL
.	NULL

Ho	NULL
S.N	NULL
.	NULL

,	NULL
THomas	NULL
D.J	NULL
.	NULL

,	NULL
TIMMERMAN	NULL
L.A.	NULL
,	NULL
L1	NULL
X.	NULL
,	NULL
Francke	NULL
U	NULL
.	NULL

&	NULL
CrRABTREE	NULL
G.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATce	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
270	NULL
,	NULL
19898	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
93	NULL
,	NULL
350-357	NULL
19	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
in	NULL
T	NULL
lymphocytes	NULL
357	NULL
Ponts	NULL
P.	NULL
,	NULL
No	NULL
S.-Y	NULL
.	NULL

,	NULL
Enoet	NULL
J.	NULL
,	NULL
Gunning	NULL
P.	NULL
&	NULL
Kepes	NULL
L.	NULL
(	NULL
1984	NULL
)	NULL
Evolutionary	NULL
conservation	NULL
in	NULL
the	NULL
untranslated	NULL
regions	NULL
of	NULL
actin	NULL
mRNAs	NULL
:	NULL
DNA	NULL
sequence	NULL
of	NULL
a	NULL
human	NULL
beta-actin	NULL
cDNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
12	NULL
,	NULL
1687	NULL
.	NULL

Ronnt	NULL
T.	NULL
,	NULL
SarenEva	NULL
T.	NULL
,	NULL
Pirmonen	NULL
J	NULL
.	NULL

&	NULL
JurkuNnen	NULL
L	NULL
(	NULL
1995	NULL
)	NULL
Activation	NULL
of	NULL
IFN-4	NULL
,	NULL
IFN-y	NULL
,	NULL
MxA	NULL
,	NULL
and	NULL
IFN	NULL
regulatory	NULL
factor	NULL
1	NULL
genes	NULL
in	NULL
influenza	NULL
A	NULL
virus-infected	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
J	NULL
Immunol	NULL
154	NULL
,	NULL
2764	NULL
.	NULL

CLIPSTONE	NULL
N.A	NULL
.	NULL

&	NULL
CrRaBTREE	NULL
G.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signaling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
357	NULL
,	NULL
695	NULL
.	NULL

CaRrTER	NULL
B.Z	NULL
.	NULL

&	NULL
MarteR	NULL
J.S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biology	NULL
of	NULL
disease	NULL
:	NULL
regulation	NULL
of	NULL
mRNA	NULL
stability	NULL
and	NULL
its	NULL
relevance	NULL
to	NULL
disease	NULL
.	NULL

Lab	NULL
Invest	NULL
65	NULL
,	NULL
610	NULL
.	NULL

Rooney	NULL
J.W	NULL
.	NULL

,	NULL
Sun	NULL
Y.-A	NULL
.	NULL

,	NULL
GuimcHER	NULL
LH	NULL
.	NULL

&	NULL
Hoey	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mo/	NULL
Cell	NULL
Biol	NULL
15	NULL
,	NULL
6299	NULL
.	NULL

Kasarnara	NULL
T.	NULL
,	NULL
Hooks	NULL
J.J.	NULL
,	NULL
Dououerty	NULL
S.F	NULL
.	NULL

&	NULL
OppenHEIM	NULL
J.J.	NULL
(	NULL
1983	NULL
)	NULL
Interleukin	NULL
2-mediated	NULL
immune	NULL
interferon	NULL
(	NULL
IFN-gamma	NULL
)	NULL
production	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
Tcell	NULL
subsets	NULL
.	NULL

J	NULL
Immunol	NULL
130	NULL
,	NULL
1784	NULL
.	NULL

Lvo	NULL
C.	NULL
,	NULL
BurGEON	NULL
E.	NULL
,	NULL
Carew	NULL
J.A	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
Cell	NULL
Bio	NULL
!	NULL

16	NULL
,	NULL
3955	NULL
.	NULL

Rooney	NULL
J.	NULL
W.	NULL
,	NULL
Hoey	NULL
T.	NULL
&	NULL
GumcHER	NULL
LH	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2	NULL
,	NULL
473	NULL
.	NULL

Penix	NULL
L.	NULL
,	NULL
Weaver	NULL
W.M	NULL
.	NULL

,	NULL
Pang	NULL
Y.	NULL
,	NULL
Young	NULL
HA	NULL
.	NULL

&	NULL
C.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Two	NULL
essential	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
interferon-y	NULL
promoter	NULL
confer	NULL
activation	NULL
specific	NULL
expression	NULL
in	NULL
T	NULL
cell	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
178	NULL
,	NULL
1483	NULL
.	NULL

AunE	NULL
TM	NULL
.	NULL

,	NULL
Penix	NULL
L.	NULL
,	NULL
Rmcon	NULL
MR.	NULL
&	NULL
FravELL	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Differential	NULL
transcription	NULL
directed	NULL
by	NULL
discrete	NULL
elements	NULL
in	NULL
naive	NULL
and	NULL
memory	NULL
(	NULL
effector	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Bio	NULL
!	NULL

17	NULL
,	NULL
199	NULL
.	NULL

NortHROP	NULL
J.P.	NULL
,	NULL
Ho	NULL
S.N	NULL
.	NULL

,	NULL
CHEN	NULL
L.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369	NULL
,	NULL
497	NULL
.	NULL

ARAMBURU	NULL
J.	NULL
,	NULL
AZZONI	NULL
L.	NULL
,	NULL
Rao	NULL
A	NULL
.	NULL

&	NULL
Perussia	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Activation	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
,	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
regulation	NULL
upon	NULL
CD16	NULL
ligand	NULL
binding	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
182	NULL
,	NULL
801	NULL
.	NULL

